Strategies to reduce corticosteroid-related adverse events in asthma
Authors:
- 1 February 2019
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Allergy and Clinical Immunology
- Vol. 19 (1) , 61-67
Abstract
Purpose of review: Severe asthmatics, despite the chronic use of high inhaled corticosteroids (ICS) doses and frequent intake of systemic corticosteroids, remains clinically and/or functionally uncontrolled. These patients are also often affected by rhinitis or chronic rhinosinusitis requiring frequent use of intranasal corticosteroids. Therefore, severe asthmatics are exposed to an overload of corticosteroids that is frequently associated with relevant and costly adverse events. This clinical problem and the strategies to overcome it are here summarized. Recent findings: Different therapeutic options may help in reducing the corticosteroid load in asthmatics, ranging from allergy immunotherapy (nonsuitable for severe uncontrolled patients), immunosuppressant agents like methotrexate or cyclosporine, novel biologic drugs (mainly anti-IgE, anti-IL5 and anti-IL4-receptor-alpha), and aspirin desensitization (for patients with anti-inflammatory drugs exacerbated respiratory disease). Summary: The evidence of even serious corticosteroid-related adverse events associated with consistent health-care costs, should prompt the entire scientific community and health regulatory authorities to promote actions to increase the use of well tolerated and effective strategies to reduce the corticosteroid need in asthmatics; the most promising option seems to be the add-on use of biologic agents.Keywords
This publication has 56 references indexed in Scilit:
- Effectiveness of Omalizumab in Severe Allergic Asthma: A Retrospective UK Real-World StudyJournal of Asthma, 2013
- Correlation of vitamin D with Foxp3 induction and steroid-sparing effect of immunotherapy in asthmatic childrenAnnals of Allergy, Asthma & Immunology, 2012
- Oral corticosteroid sparing with omalizumab in severe allergic (IgE-mediated) asthma patientsCurrent Medical Research and Opinion, 2011
- Association between Severity of Asthma and Degree of Chronic RhinosinusitisAmerican Journal of Rhinology & Allergy, 2011
- Vitamin D Serum Levels and Markers of Asthma Control in Italian ChildrenThe Journal of Pediatrics, 2011
- Steroid-sparing effects with allergen-specific immunotherapy in children with asthma: A randomized controlled trialJournal of Allergy and Clinical Immunology, 2010
- An evaluation of the cost‐effectiveness of omalizumab for the treatment of severe allergic asthmaAllergy, 2008
- Guidelines for the management of rheumatoid arthritis: 2002 UpdateArthritis & Rheumatism, 2002
- Natural history of aspirin-induced asthmaEuropean Respiratory Journal, 2000
- Efficacy and safety of low-dose troleandomycin therapy in children with severe, steroid-requiring asthmaJournal of Allergy and Clinical Immunology, 1993